April 15, 2025
TOPLINE: US hospitalizations related to cervical artery dissection (CeAD) increased more than fourfold between 2005 and 2019, suggested a new study that also showed vertebral artery […]
April 15, 2025
TOPLINE: Poor oral health was associated with increased migraines and abdominal and body pain in women with central sensitization disorders, with risk for specific pain conditions […]
April 14, 2025
The US Food and Drug Administration (FDA) has approved a prefilled syringe for self-injection of efgartigimod alfa and hyaluronidase-qvfc (Vyvgart Hytrulo, argenx) in the treatment of […]
April 14, 2025
SAN DIEGO — Tolebrutinib, a novel Bruton’s tyrosine kinase (BTK) inhibitor that targets neuroinflammation, slowed disability progression by 31% in patients with nonrelapsing secondary progressive multiple […]
April 11, 2025
SAN DIEGO — New data confirmed the safety and efficacy of AXS-05, a combination of dextromethorphan and bupropion, for the treatment of agitation associated with Alzheimer’s […]
April 10, 2025
The National Institute for Health and Care Excellence (NICE) has published a draft guideline aimed at standardising rehabilitation services across five chronic neurological conditions. The guidance […]
April 10, 2025
SAN DIEGO — Transcutaneous peripheral nerve stimulation delivered via a wristband has shown promise in treating essential tremor (ET), a common movement disorder that significantly affects […]
April 10, 2025
SAN DIEGO — Inebilizumab (Uplizna, Amgen) is safe and effective up to 52 weeks in patients with generalized myasthenia gravis (MG), new research suggested. If approved, the […]
April 9, 2025
SAN DIEGO — An adjunctive, first-in-class investigational prescription digital therapeutic significantly reduced monthly migraine days (MMDs) in patients with episodic migraine (EM) compared with sham results […]